Zimmer Biomet Holdings, Inc.ZBHNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-14.6%
5Y CAGR-12.2%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-14.6%/yr
Quarterly compound
5Y CAGR
-12.2%/yr
Consistent
Percentile
P74
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 6.86% |
| Q3 2025 | -0.42% |
| Q2 2025 | 7.38% |
| Q1 2025 | 1.59% |
| Q4 2024 | 5.24% |
| Q3 2024 | -3.72% |
| Q2 2024 | 0.12% |
| Q1 2024 | 1.92% |
| Q4 2023 | 7.02% |
| Q3 2023 | -7.01% |
| Q2 2023 | 1.38% |
| Q1 2023 | -1.54% |
| Q4 2022 | 11.02% |
| Q3 2022 | -5.80% |
| Q2 2022 | 1.56% |
| Q1 2022 | -26.71% |
| Q4 2021 | 36.47% |
| Q3 2021 | -1.78% |
| Q2 2021 | 6.06% |
| Q1 2021 | -26.50% |
| Q4 2020 | 13.15% |
| Q3 2020 | 18.80% |
| Q2 2020 | -19.77% |
| Q1 2020 | -5.48% |
| Q4 2019 | 6.12% |
| Q3 2019 | -1.48% |
| Q2 2019 | 5.32% |
| Q1 2019 | -20.25% |
| Q4 2018 | 26.77% |
| Q3 2018 | -0.45% |
| Q2 2018 | -1.30% |
| Q1 2018 | -8.76% |
| Q4 2017 | 23.46% |
| Q3 2017 | -5.38% |
| Q2 2017 | -11.38% |
| Q1 2017 | -23.31% |
| Q4 2016 | 33.12% |
| Q3 2016 | 3.05% |
| Q2 2016 | 12.54% |
| Q1 2016 | -34.82% |